Citigroup’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.5M | Buy |
|
|||||
|
2025
Q1 | $1.63M | Sell |
|
|||||
|
2024
Q4 | $2.1M | Buy |
|
|||||
|
2024
Q3 | $2.02M | Buy |
|
|||||
|
2024
Q2 | $415K | Sell |
|
|||||
|
2024
Q1 | $674K | Buy |
|
|||||
|
2023
Q4 | $79.4K | Buy |
|
|||||
|
2023
Q3 | $6.75K | Sell |
|
|||||
|
2023
Q2 | $111K | Buy |
|
|||||
|
2023
Q1 | $4.8K | Sell |
|
|||||
|
2022
Q4 | $8.25K | Sell |
|
|||||
|
2022
Q3 | $10K | Sell |
|
|||||
|
2022
Q2 | $24K | Buy |
|
|||||
|
2022
Q1 | $24K | Sell |
|
|||||
|
2021
Q4 | $173K | Buy |
|
|||||
|
2021
Q3 | $25K | Buy |
|
|||||
|
2021
Q2 | $13K | Buy |
|